GLUT1 Gene as a Hypoxic Marker in Colorectal Cancer
Author Information
Author(s): Chung Fu-Yen, Huang Ming-Yii, Yeh Ching-Sheng, Chang Hui-Jen, Cheng Tian-Lu, Yen Li-Chen, Wang Jaw-Yuan, Lin Shiu-Ru
Primary Institution: Kaohsiung Medical University, Kaohsiung, Taiwan
Hypothesis
This study investigates the potential of GLUT1 as a molecular probe for detecting hypoxia in colorectal cancer patients.
Conclusion
GLUT1 may serve as a molecular marker to indicate the degree of hypoxia in tumors circulating in the blood of cancer patients.
Supporting Evidence
- GLUT1 mRNA was significantly overexpressed in colorectal cancer tissue specimens.
- Elevated GLUT1 levels were associated with advanced cancer stages.
- GLUT1 expression was higher in the peripheral blood of stage II and III CRC patients compared to stage I.
Takeaway
The study found that a gene called GLUT1 can help doctors understand how much oxygen is in tumors, which is important for treating cancer.
Methodology
The study used RT-PCR to analyze GLUT1 mRNA expression in colorectal cancer cell lines and tissue samples from patients.
Limitations
The study had a small sample size for stage I patients, which may affect the interpretation of results.
Participant Demographics
Patients aged 32 to 68 years, with a mean age of 51.5 years.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website